Traditionally, Novo Nordisk's insulin developers had worked separately from those involved in delivering the insulin to the patient. To achieve the company's new focus on the patient these two groups were brought together in a new division called Protein Delivery Systems.
PA helped overcome some major challenges including: the integration of two existing groups and new recruits; alignment with the overall strategy; and the creation of a unique culture - as well as getting on with innovation.
To find out more about improving your innovation performance please contact us now.
PRINT
EMAIL
TWITTER
LINKEDIN
FACEBOOK
FEEDS